Business Standard

Sunday, December 22, 2024 | 06:43 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

More than enough doses of Covid-19 vaccine reserved for Parsis: Poonawalla

Serum Institute CEO didn't specify quantity of doses to be kept for community grappling with shrinking population

Adar Poonawalla, CEO, Serum Institute
Premium

He said as part of the agreement with AstraZeneca, SII can manufacture one billion doses for India and nearly 70 low and middle income countries.

Press Trust of India Pune
"More than enough" doses of the Covid-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the Parsi community, Adar Poonawalla, chief executive officer of the vaccine's local manufacturer Serum Institute of India (SII), has said.

Poonawalla, however, did not specify the quantity of the doses that will be kept for the community, which is grappling with shrinking population.

Replying to producer Ronnie Screwvala on Twitter, Poonawalla on Sunday said, "Yes @RonnieScrewvala, we will keep more than enough for the community. Our production capacity of just one day will be enough to cover every Parsi on the planet...given

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in